MINI FUTURE LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 20:50:27 27/06/2024 BST | ||
| 3.01 EUR | -3.22% |
|
| Current month | -7.46% | ||
| 1 month | -9.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 3.1 | -0.32% |
| 26/06/24 | 3.11 | -0.64% |
| 25/06/24 | 3.13 | -4.57% |
| 24/06/24 | 3.28 | +3.47% |
| 21/06/24 | 3.17 | +2.59% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YY9 |
| ISIN | DE000PZ0YY93 |
| Date issued | 03/11/2023 |
| Strike | 105.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.82 € |
|---|---|
| Lowest since issue | 1.9 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.03%
- Stock Market
- Certificates
- Certificat
